🇺🇸 FDA
Patent

US 10329338

Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon

granted A61KA61K2039/505A61K2039/55522

Quick answer

US patent 10329338 (Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon) held by The Regents of the University of Colorado expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2039/55522, A61K38/00, A61K39/12